Montville, NJ, United States of America

Larry McKay

This inventor holds 2 USPTO granted patents. Top assignee: Arthritis Relief Plus Ltd.. Active years: 2019-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Larry McKay - Innovator in Topical Formulations

Introduction

Larry McKay is a notable inventor based in Montville, NJ (US). He has made significant contributions to the field of topical formulations, particularly in the treatment of inflammatory and degenerative conditions. With a total of 2 patents to his name, McKay's work is recognized for its innovative approach to utilizing natural compounds.

Latest Patents

McKay's latest patents focus on topical formulations that incorporate comfrey or comfrey-derived compounds. One of his inventions provides a formulation that includes a penetration enhancer and optionally tannic acid. This formulation aims to enhance the therapeutic effects of the active ingredients. Another patent similarly emphasizes the combination of comfrey and tannic acid, with methods for prophylactic or therapeutic treatment of various conditions.

Career Highlights

Larry McKay is associated with Arthritis Relief Plus Ltd., where he continues to develop and refine his innovative formulations. His work is pivotal in advancing treatments that leverage natural ingredients for health benefits.

Collaborations

McKay collaborates with notable colleagues such as Kanu Patel and Robert John Capon, contributing to a dynamic team focused on innovation in the health sector.

Conclusion

Larry McKay's contributions to topical formulations highlight his commitment to improving health outcomes through innovative solutions. His patents reflect a blend of natural ingredients and scientific research aimed at addressing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…